文献速递乳腺MR

Wavelia微波乳腺成像系统的肿瘤鉴别特征及其临床实用性

The Wavelia Microwave Breast Imaging system-tumour discriminating features and their clinical usefulness.
PubMed 文献 · Br J Radiol · 2021-10-05

本研究评估Wavelia微波乳腺成像系统在有症状患者中估计乳腺病变大小和恶性风险的能力。24例患者分为乳腺癌组、未抽吸囊肿组和活检良性病变组,结果显示该系统在乳腺癌大小估计上比常规影像更准确,QDA分类器准确区分良恶性达88.5%。两位乳腺放射科医生认为在70.6%的病例中MBI及恶性风险计算有临床帮助。

要点

  • Wavelia MBI在乳腺癌大小估计上比常规影像更准确。
  • QDA分类器在3D特征空间区分乳腺良恶性病变准确率为88.5%。
  • 放射科医生认为MBI及恶性风险计算在70.6%病例中有临床帮助。

核心结论

  • Wavelia MBI系统在估计乳腺病变大小和恶性风险方面展现出潜力,可作为乳腺癌诊断的无创、舒适且无害的辅助手段。

研究设计与样本

  • 单中心研究,纳入24例有症状患者,分为乳腺癌组(11例)、未抽吸囊肿组(8例)和活检良性病变组(5例),均接受MBI检查并与常规影像及组织病理学对照。
  • 采用二次判别分析(QDA)分类器在3D特征空间中进行良恶性鉴别,并由两位独立乳腺放射科医生进行独立评估。

诊断标准与关键数值

  • QDA分类器在3D特征空间中区分乳腺良恶性病变的准确率为88.5%。
  • 两位放射科医生认为MBI及Wavelia恶性风险计算在70.6%的病例中有用。

临床应用与阅片要点

  • MBI可作为有症状患者乳腺病变评估的辅助手段,尤其关注其大小估计和恶性风险计算对临床决策的帮助。
  • 需注意本研究样本量小,结果需更大规模研究验证,目前不应替代常规影像和组织病理学诊断。

局限性

  • 样本量小(共24例),为单中心研究,结果需进一步 larger studies 验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The Wavelia Microwave Breast Imaging (MBI) system, based on non-ionising imaging technology, has demonstrated exciting potential in the detection and localisation of breast pathology in symptomatic patients. In this study, the ability of the system to accurately estimate the size and likelihood of malignancy of breast lesions is detailed, and its clinical usefulness determined.

METHODS: Institutional review board and Health Products Regulatory Authority (HPRA) approval were obtained. Patients were recruited from the symptomatic unit to three groups; breast cancer (Group-1), unaspirated cysts (Group-2) and biopsied benign lesions (Group-3). MBI, radiological and histopathological findings were reviewed. MBI size estimations were compared with the sizes determined by conventional imaging and histopathology. A Quadratic Discriminant Analysis (QDA) classifier was trained in a 3D feature space to discriminate malignant from benign lesions. An independent review was performed by two independent breast radiologists.

RESULTS: 24 patients (11 Group-1, 8 Group-2 and 5 Group-3) underwent MBI. The Wavelia system was more accurate than conventional imaging in size estimation of breast cancers. The QDA accurately separated benign from malignant breast lesions in 88.5% of cases. The addition of MBI and the Wavelia malignancy risk calculation was deemed useful by the two radiologists in 70.6% of cases.

CONCLUSION: The results from this MBI investigation demonstrate the potential of this novel system in estimating size and malignancy risk of breast lesions. This system holds significant promise as a potential non-invasive, comfortable, and harmless adjunct for breast cancer diagnosis. Further larger studies are under preparation to validate the findings of this study.

ADVANCES IN KNOWLEDGE: This study details the potential of the Wavelia MBI system in delineating size and malignancy risk of benign and malignant breast lesions in a symptomatic cohort. The usefulness of the Wavelia system is assessed in the clinical setting.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Moloney BM, McAnena PF, Elwahab SM, et al. The Wavelia Microwave Breast Imaging system-tumour discriminating features and their clinical usefulness. Br J Radiol. 2021. PMID: 34581186. doi:10.1259/bjr.20210907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。